STAT+: Pharmalittle: Next big hope for Alzheimer’s might not help most Black patients; drugmakers ask Supreme Court to toss terrorism-support ruling
Critics say any positive impact from the Alzheimer's drug Leqembi will not benefit lower-income patients, who tend to be diagnosed too late.
by Ed Silverman
Jul 06, 2023
3 minutes
Top of the morning to you, and a fine one it is. Cool breezes and clear blue skies – at least for now – are wafting above the Pharmalot campus, where the official mascots are settling in for a well-deserved snooze. As for us, we are busy with the usual sorts of things. We are quaffing another cup of stimulation – our choice today is gingerbread – are attempting to get organized, a Quixotic notion in our world. Nonetheless, we are giving it a go.
You’re reading a preview, subscribe to read more.
Start your free 30 days